Over-the-counter healthcare products play a critical role in addressing everyday medical needs, from minor pain relief to allergy management. As consumer demand grows, the OTC pharmaceuticals market is projected to reach significant revenue growth in the years ahead. In today’s FA Alpha Daily, we explore how Prestige Consumer Healthcare (PBH) is strategically positioned within this expanding market and assess the potential implications for long-term investors.
Cancer is one of the most formidable health challenges American society is facing today. In the U.S. alone, the oncology market is valued at around $250 billion, encompassing the various diagnostic, pharmaceutical, and supportive care services aimed at treating different types of cancers.
An aging U.S. school bus fleet is pushing municipalities toward a major replacement cycle. Amid this shift, one bus manufacturer has emerged as the only pure-play option positioned to benefit from rising state and local spending. In today’s FA Alpha Daily, we explore how Blue Bird is capturing this unique opportunity and what it could […]
Soaring energy demand and recent policy changes are shaping the future of renewable power, with solar still set to lead the way. Nextracker’s strong technology, global presence, and AI-driven innovations position it to benefit from this growth despite industry challenges. In today’s FA Alpha Daily, we explain why Nextracker (NXT) could become a major winner in the solar market and why the market may not yet fully appreciate its potential.
The U.S. government and corporate America have severely underinvested in its infrastructure so far this century. For years, corporations were able to get away with this thanks to "just in time" practices, holding only enough materials to meet current demand.
Investing has shifted from stock picking to passive index strategies, and BlackRock (BLK) has been one of the biggest winners of this trend. Its dominance in ETFs and steady expansion into private markets have helped it quietly build over $12.5 trillion in assets. Yet despite its massive scale and consistent growth, the market may still be overlooking its upside potential. In today’s FA Alpha Daily, we look at why BlackRock could have even more room to run.
Artificial intelligence has been at the forefront of the market for the last year as new advancements in technology continue to show industry-altering potential.
U.S. infrastructure investment is surging across both public and private sectors, fueled by government spending, reshoring efforts, and the AI-driven data center boom. Positioned at the center of this trend, Oshkosh’s high-return Access and Vocational segments are benefiting from strong demand. In today's FA Alpha Daily, we explore why the market undervalues Oshkosh's potential due to cyclical concerns and how this could be a possible opportunity for long-term investors.
There has been a significant amount of news and articles recently about the shift to passive investment strategies and the decline of active equity management.
Generic drugs often fly under the radar, but ANI Pharmaceuticals (ANIP) is using them to fuel high-margin growth. By reinvesting steady cash flows into rare disease treatments like TEZRULY and INZIRQO, the company is carving out a profitable niche. In today’s FA Alpha Daily, we explore how ANI’s strategy supports strong returns and why the market may be underestimating its upside.
The U.S. senior population is growing rapidly, driven by the aging baby boomer generation. Current projections put Americans age 65 and older at about 82 million by 2050.
Bitcoin ETFs only began trading on major stock exchanges in January 2024, with the approval of the first United States spot Bitcoin ETFs by the Securities and Exchange Commission (“SEC”).
